NPORT-EX 2 bad.htm
B.A.D. ETF
 
Schedule of Investments
 
August 31, 2023 (Unaudited)
 
   
Shares
   
Value
 
COMMON STOCKS - 99.7%
           
Beverages-Wine/Spirits — 13.4%
           
Brown-Forman Corp. - Class B
   
4,428
   
$
292,824
 
Cia Cervecerias Unidas SA - ADR (b)
   
18,167
     
267,600
 
Diageo PLC - ADR (b)
   
1,705
     
282,433
 
MGP Ingredients, Inc.
   
2,850
     
341,715
 
The Duckhorn Portfolio, Inc. (a)
   
21,105
     
262,546
 
             
1,447,118
 
Brewery — 13.6%
               
Ambev SA - ADR (b)
   
96,889
     
268,383
 
Anheuser-Busch InBev SA/NV - ADR (b)
   
5,270
     
299,810
 
Constellation Brands, Inc. - Class A
   
1,193
     
310,848
 
Molson Coors Beverage Co. - Class B
   
4,378
     
277,959
 
The Boston Beer Co., Inc. - Class A (a)
   
871
     
318,290
 
             
1,475,290
 
Casino Hotels — 9.3%
               
Boyd Gaming Corp.
   
2,980
     
199,273
 
Las Vegas Sands Corp.
   
3,561
     
195,356
 
Melco Resorts & Entertainment Ltd. - ADR (a)(b)
   
16,884
     
189,438
 
MGM Resorts International
   
4,921
     
216,426
 
Wynn Resorts Ltd.
   
1,984
     
201,138
 
             
1,001,631
 
Casino Services — 6.0%
               
Caesars Entertainment, Inc. (a)
   
4,213
     
232,810
 
Everi Holdings, Inc. (a)
   
12,864
     
186,013
 
Light & Wonder, Inc. (a)
   
3,050
     
233,844
 
             
652,667
 
Consumer Products-Misc. — 3.2%
               
Cronos Group, Inc. (b)
   
171,175
     
350,909
 
                 
Gambling (Non-Hotel) — 7.0%
               
Golden Entertainment, Inc. (a)
   
4,475
     
162,935
 
International Game Technology PLC (b)
   
6,494
     
207,938
 
Monarch Casino & Resort, Inc.
   
2,930
     
197,482
 
Red Rock Resorts, Inc. - Class A
   
4,192
     
184,154
 
             
752,509
 
Internet Gambling— 6.1%
               
DraftKings, Inc. - Class A (a)
   
8,015
     
237,645
 
Genius Sports Ltd. (a)(b)
   
34,336
     
227,991
 
Sportradar Holding AG - Class A (a)(b)
   
16,654
     
191,854
 
             
657,490
 
Medical-Biomedical/Genetics— 14.9%
               
Amgen, Inc.
   
715
     
183,283
 
BeiGene, Ltd. - ADR (a)(b)
   
730
     
151,512
 
Biogen, Inc. (a)
   
519
     
138,760
 
BioNTech SE - ADR (a)(b)
   
1,455
     
175,953
 
Genmab A/S - ADR (a)(b)
   
4,069
     
155,802
 
Gilead Sciences, Inc.
   
2,042
     
156,172
 
Moderna, Inc. (a)
   
1,263
     
142,807
 
Regeneron Pharmaceuticals, Inc. (a)
   
211
     
174,389
 
Seagen, Inc. (a)
   
812
     
167,329
 
Vertex Pharmaceuticals, Inc. (a)
   
477
     
166,158
 
             
1,612,165
 
Medical-Drugs — 22.8%
               
AbbVie, Inc.
   
1,165
     
171,208
 
AstraZeneca PLC - ADR (b)
   
2,123
     
143,982
 
Bristol-Myers Squibb Co.
   
2,449
     
150,981
 
Eli Lilly & Co.
   
356
     
197,295
 
GSK PLC - ADR (b)
   
4,555
     
160,017
 
Johnson & Johnson
   
989
     
159,902
 
Merck & Co., Inc.
   
1,457
     
158,784
 
Novartis AG - ADR (b)
   
1,569
     
157,653
 
Novo Nordisk A/S - ADR (b)
   
987
     
183,207
 
Pfizer, Inc.
   
4,101
     
145,093
 
Sanofi - ADR (b)
   
3,077
     
163,635
 
Takeda Pharmaceutical Co. Ltd. - ADR (b)
   
9,835
     
151,459
 
Tilray Brands, Inc. (a)
   
174,587
     
516,778
 
             
2,459,994
 
Racetracks — 3.4%
               
Churchill Downs, Inc.
   
1,453
     
182,032
 
Penn Entertainment, Inc. (a)
   
7,714
     
182,745
 
             
364,777
 
TOTAL COMMON STOCKS (Cost $10,860,770)
           
10,774,550
 
                 
SHORT-TERM INVESTMENTS — 0.2%
               
Money Market Fund — 0.2%
               
First American Government Obligations Fund - Class X, 5.25% (c)
   
19,963
     
19,963
 
TOTAL SHORT-TERM INVESTMENTS (Cost $19,963)
           
19,963
 
                 
TOTAL INVESTMENTS (Cost $10,880,733) — 99.9%
           
10,794,513
 
Other assets and liabilities, net — 0.1%
           
9,941
 
NET ASSETS — 100.0%
           
10,804,454
 

Percentages are stated as a percent of net assets
             
                 
ADR
American Depositary Receipt
             
PLC
Public Limited Company
             
(a)
Non-income producing security.
             
(b)
Foreign issued security, or represents a foreign issued security.
             
(c)
The rate shown is the seven-day yield at period end.
             

Fair Value Measurements
             
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels.
       
Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs
       
(including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant
       
unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the
     
securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
       
                 
The Fund did not hold any investments during the period with significant unobservable inputs which would be classified as Level 3.
     
                 
The following is a summary of the inputs used to value the Fund’s investments carried at fair value as of August 31, 2023:
       

   
Level 1
   
Level 2
   
Level 3
   
Total
 
Investments - Assets:
                       
Common Stocks*
 
$
10,774,550
   
$
-
   
$
-
   
$
10,774,550
 
Money Market Fund
   
19,963
     
-
     
-
     
19,963
 
Total Investments - Assets
 
$
10,794,513
   
$
-
   
$
-
   
$
10,794,513
 
                                 
* See the Schedule of Investments for industry classifications.